These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12218466)

  • 1. Clinical research in pediatric ophthalmology: the Pediatric Eye Disease Investigator Group.
    Beck RW
    Curr Opin Ophthalmol; 2002 Oct; 13(5):337-40. PubMed ID: 12218466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-year follow-up of a 6-month randomized trial of atropine vs patching for treatment of moderate amblyopia in children.
    Repka MX; Wallace DK; Beck RW; Kraker RT; Birch EE; Cotter SA; Donahue S; Everett DF; Hertle RW; Holmes JM; Quinn GE; Scheiman MM; Weakley DR;
    Arch Ophthalmol; 2005 Feb; 123(2):149-57. PubMed ID: 15710809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atropine vs. patching for the treatment of moderate amblyopia in children.
    Kushner BJ
    Arch Ophthalmol; 2002 Mar; 120(3):387-8. PubMed ID: 11879145
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of atropine and patching treatments for moderate amblyopia by patient age, cause of amblyopia, depth of amblyopia, and other factors.
    Pediatric Eye Disease Investigator Group
    Ophthalmology; 2003 Aug; 110(8):1632-7; discussion 1637-8. PubMed ID: 12917184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEDIG study on amblyopia; vision therapy by atropine penalization versus occlusion.
    Kowal L
    Binocul Vis Strabismus Q; 2002; 17(4):275. PubMed ID: 12470288
    [No Abstract]   [Full Text] [Related]  

  • 6. Compliance and patching and atropine amblyopia treatments.
    Wang J
    Vision Res; 2015 Sep; 114():31-40. PubMed ID: 25743080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concern about the Pediatric Eye Disease Investigator Group 2-year follow-up study.
    Kushner BJ
    Arch Ophthalmol; 2005 Nov; 123(11):1615-6. PubMed ID: 16286633
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of patching and atropine treatment on the child and family in the amblyopia treatment study.
    Holmes JM; Beck RW; Kraker RT; Cole SR; Repka MX; Birch EE; Felius J; Christiansen SP; Coats DK; Kulp MT;
    Arch Ophthalmol; 2003 Nov; 121(11):1625-32. PubMed ID: 14609923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of pediatric amblyopia.
    Lederman ME; Pollard Z; Olitsky S
    J Pediatr Ophthalmol Strabismus; 2004; 41(5):263-7. PubMed ID: 15478738
    [No Abstract]   [Full Text] [Related]  

  • 10. The course of moderate amblyopia treated with patching in children: experience of the amblyopia treatment study.
    Pediatric Eye Disease Investigator Group
    Am J Ophthalmol; 2003 Oct; 136(4):620-9. PubMed ID: 14516801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical translation of recommendations from randomized clinical trials on patching regimen for amblyopia.
    Jin YP; Chow AH; Colpa L; Wong AM
    Ophthalmology; 2013 Apr; 120(4):657-62. PubMed ID: 23395531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are amblyopia treatments really all equal? Is that even the right question?
    Archer SM
    Am Orthopt J; 2012; 62():1-3. PubMed ID: 22848111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Combined Occlusion and Atropine Therapy" Versus "Augmented Part-Time Patching" in Children with Refractory/Residual Amblyopia: A Pilot Study.
    Sachdeva V; Mittal V; Gupta V; Gunturu R; Kekunnaya R; Chandrasekharan A; Chabblani PP; Rao HL
    Middle East Afr J Ophthalmol; 2016; 23(2):201-7. PubMed ID: 27162453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trial of patching versus atropine penalization for the treatment of anisometropic amblyopia in older children.
    Menon V; Shailesh G; Sharma P; Saxena R
    J AAPOS; 2008 Oct; 12(5):493-7. PubMed ID: 18534880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of treatment of amblyopia in children aged 7 to 17 years.
    Scheiman MM; Hertle RW; Beck RW; Edwards AR; Birch E; Cotter SA; Crouch ER; Cruz OA; Davitt BV; Donahue S; Holmes JM; Lyon DW; Repka MX; Sala NA; Silbert DI; Suh DW; Tamkins SM;
    Arch Ophthalmol; 2005 Apr; 123(4):437-47. PubMed ID: 15824215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect on refractive error of unilateral atropine as compared with patching for the treatment of amblyopia.
    Repka MX; Melia M; Eibschitz-Tsimhoni M; London R; Magoon E;
    J AAPOS; 2007 Jun; 11(3):300-2. PubMed ID: 17572346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The course of moderate amblyopia treated with atropine in children: experience of the amblyopia treatment study.
    Pediatric Eye Disease Investigator Group
    Am J Ophthalmol; 2003 Oct; 136(4):630-9. PubMed ID: 14516802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of amblyopia therapy on ocular alignment.
    Repka MX; Holmes JM; Melia BM; Beck RW; Gearinger MD; Tamkins SM; Wheeler DT;
    J AAPOS; 2005 Dec; 9(6):542-5. PubMed ID: 16414520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amblyopia treatment: 1998 versus 2004.
    Khazaeni L; Quinn GE; Davidson SL; Forbes BJ
    J Pediatr Ophthalmol Strabismus; 2009; 46(1):19-22; quiz 23-4. PubMed ID: 19213272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Compliance and patching and atropine amblyopia treatments"--Reply to Letter to the Editor.
    Wang J
    Vision Res; 2015 Oct; 115(Pt A):153-4. PubMed ID: 26277264
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.